{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/measles/","result":{"data":{"firstChapter":{"id":"574596e7-391a-5ae2-bf0e-e7a3ac0db310","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 4a2badba-3da1-4699-bb68-343b158c45a6 --><h1>Measles: Summary</h1><!-- end field 4a2badba-3da1-4699-bb68-343b158c45a6 -->","htmlStringContent":"<!-- begin item c3db1250-7cfb-4a5d-8f25-05ab230eff37 --><!-- begin field aca8b80f-fdae-4430-9a3e-8c654da410d7 --><ul><li>Measles is a highly contagious airborne infection caused by a morbillivirus of the paramyxovirus family. <ul><li>It infects, via the respiratory tract, nearly all susceptible people who come into contact with it. Once infected, the person develops lifelong immunity.</li></ul></li><li>Although endemic in the UK in the past, measles has become relatively rare since the introduction of measles immunization. </li><li>The main complications of measles are of the respiratory tract or central nervous system and include:<ul><li>Otitis media.</li><li>Pneumonia, pneumonitis, and tracheobronchitis.</li><li>Convulsions, encephalitis, and blindness.</li><li>Subacute sclerosing panencephalitis (a rare but serious complication affecting about 1 in 25,000 people with measles).</li></ul></li><li>Measles tends to be more severe in adults, infants, pregnancy, and immunocompromised people.</li><li>Measles is usually a self-limiting condition; symptoms usually resolve over the course of about a week. Prodromal symptoms include fever, cough, coryza, and conjunctivitis. These symptoms, in addition to the appearance of a characteristic maculopapular rash (with or without Koplik's spots), are highly suggestive of measles.</li><li>Other infections that may be misdiagnosed as measles include:<ul><li>Parvovirus B19, the virus that causes fifth disease (slapped cheek syndrome).</li><li>Streptococcal infection (for example scarlet fever).</li><li>Herpes virus type 6 (roseola infantum).</li><li>Rubella.</li><li>Early meningococcal disease.</li></ul></li><li>If a diagnosis of measles is suspected, it is essential to notify the local Health Protection Team (HPT), and it may be necessary to confirm the infection through laboratory investigation.<ul><li>The person should be advised to rest, drink adequate fluids, and take paracetamol or ibuprofen for symptomatic relief.</li><li>People with measles should stay away from school or work for 4 days after the initial development of the rash, and avoid contact with susceptible people (people who are not fully immunized through vaccination or natural exposure, infants, pregnant women, or immunocompromised people).</li><li>Further advice should be obtained from the local HPT regarding the management of people who are immunocompromised, pregnant women, and infants.</li></ul></li><li>Admission may be necessary if the person develops a serious complication of measles, for example:<ul><li>Pneumonia.</li><li>Neurological problems, such as febrile convulsions in children, or encephalitis.</li></ul></li></ul><!-- end field aca8b80f-fdae-4430-9a3e-8c654da410d7 --><!-- end item c3db1250-7cfb-4a5d-8f25-05ab230eff37 -->","topic":{"id":"0ec66249-42a4-5c0d-8a37-f2632ca7acde","topicId":"8b32d801-8035-4957-b21d-fdc0316b697d","topicName":"Measles","slug":"measles","aliases":[],"chapters":[{"id":"574596e7-391a-5ae2-bf0e-e7a3ac0db310","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"57c95110-4970-53c3-82ca-a0a02f782b1a","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"3968756f-72d2-5af8-a135-89adf3df1291","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"ef04938f-6cd8-5d2b-8031-e63619ffaae6","slug":"changes","fullItemName":"Changes"},{"id":"109f46c2-752c-5d34-a3a9-70f89ef6e6d8","slug":"update","fullItemName":"Update"}]},{"id":"0ac61cbb-f6a3-5cde-a49e-383cf998866c","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"af44849d-419b-5236-8667-1b06697011e9","slug":"goals","fullItemName":"Goals"},{"id":"8aa254cd-c0c4-5ad2-9778-896548b9ae3d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6e5a7bc2-88e4-5518-9a27-2c4cc8f96d43","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e1e3d298-266c-53ca-a837-a43f7b51f000","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e408b673-3cc9-556a-b3ad-7f2adc0c7e2f","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4bbb33e5-786e-5140-803d-6c7d608ba7fd","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"25608b62-311c-5cfe-bf68-7953a8ee3737","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"da92a2f3-77ca-5048-8cae-2d7f1fbf552e","slug":"definition","fullItemName":"Definition"},{"id":"008ec2dd-b367-561a-8f55-c9d5ced49310","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e8947faa-ab89-5369-a4ce-5d229aab4f40","slug":"complications","fullItemName":"Complications"},{"id":"c8086ee6-6b88-546f-9784-243317583284","slug":"prognosis","fullItemName":"Prognosis"},{"id":"f0a7fac1-bcd1-58ee-bd35-7c7cdd97c2b9","slug":"prevention","fullItemName":"Prevention"}]},{"id":"8a31ee21-9f32-5c22-955c-068539025090","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"258e5d5d-350e-51b5-b153-b71e658fa8b1","slug":"clinical-diagnosis","fullItemName":"Clinical diagnosis"},{"id":"60d5992e-b9ee-5ec0-8c37-2e09959645bf","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"42c95547-93f2-5eb8-a251-1331b9a2fae0","slug":"management","fullItemName":"Management","subChapters":[{"id":"daafe6b6-2230-5141-b9ba-d35b315dae91","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"652a2cc4-a89a-59a8-b1de-8e3927ccc932","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"1735c97d-c963-573a-b8b3-b03213e77a02","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"48a021d6-c031-58e0-9b01-8978137c72a8","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c54e239c-eef4-5e71-9082-ef47671dd839","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"aaf0b0cb-35a7-52fb-96f9-e18ff97bd1b0","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6248e49f-183f-5012-b8be-5fecfed55179","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"59da5ba6-9602-5e3c-9fa7-01b556316fbe","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"31dfda31-da84-5592-9695-d7dfc3dbdaee","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"0ec66249-42a4-5c0d-8a37-f2632ca7acde","topicId":"8b32d801-8035-4957-b21d-fdc0316b697d","topicName":"Measles","slug":"measles","aliases":[],"topicSummary":"Measles is a highly contagious airborne infection caused by a morbillivirus of the paramyxovirus family.","lastRevised":"Last revised in March 2018","nextPlannedReviewBy":"2023-03-01T00:00:00+00:00","nextPlannedReviewByDateTime":"2023-03","nextPlannedReviewByDisplay":"March 2023","specialities":[{"id":"e9e3ea2b-52b8-5242-bc9d-24052ea8647a","name":"Child health","slug":"child-health"},{"id":"e174a859-759f-5b1d-898e-1a4155645e13","name":"Infections and infestations","slug":"infections-infestations"}],"chapters":[{"id":"574596e7-391a-5ae2-bf0e-e7a3ac0db310","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"57c95110-4970-53c3-82ca-a0a02f782b1a","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"3968756f-72d2-5af8-a135-89adf3df1291","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"ef04938f-6cd8-5d2b-8031-e63619ffaae6","slug":"changes","fullItemName":"Changes"},{"id":"109f46c2-752c-5d34-a3a9-70f89ef6e6d8","slug":"update","fullItemName":"Update"}]},{"id":"0ac61cbb-f6a3-5cde-a49e-383cf998866c","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"af44849d-419b-5236-8667-1b06697011e9","slug":"goals","fullItemName":"Goals"},{"id":"8aa254cd-c0c4-5ad2-9778-896548b9ae3d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6e5a7bc2-88e4-5518-9a27-2c4cc8f96d43","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e1e3d298-266c-53ca-a837-a43f7b51f000","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e408b673-3cc9-556a-b3ad-7f2adc0c7e2f","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4bbb33e5-786e-5140-803d-6c7d608ba7fd","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"25608b62-311c-5cfe-bf68-7953a8ee3737","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"da92a2f3-77ca-5048-8cae-2d7f1fbf552e","slug":"definition","fullItemName":"Definition"},{"id":"008ec2dd-b367-561a-8f55-c9d5ced49310","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e8947faa-ab89-5369-a4ce-5d229aab4f40","slug":"complications","fullItemName":"Complications"},{"id":"c8086ee6-6b88-546f-9784-243317583284","slug":"prognosis","fullItemName":"Prognosis"},{"id":"f0a7fac1-bcd1-58ee-bd35-7c7cdd97c2b9","slug":"prevention","fullItemName":"Prevention"}]},{"id":"8a31ee21-9f32-5c22-955c-068539025090","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"258e5d5d-350e-51b5-b153-b71e658fa8b1","slug":"clinical-diagnosis","fullItemName":"Clinical diagnosis"},{"id":"60d5992e-b9ee-5ec0-8c37-2e09959645bf","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"42c95547-93f2-5eb8-a251-1331b9a2fae0","slug":"management","fullItemName":"Management","subChapters":[{"id":"daafe6b6-2230-5141-b9ba-d35b315dae91","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"652a2cc4-a89a-59a8-b1de-8e3927ccc932","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"1735c97d-c963-573a-b8b3-b03213e77a02","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"48a021d6-c031-58e0-9b01-8978137c72a8","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c54e239c-eef4-5e71-9082-ef47671dd839","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"aaf0b0cb-35a7-52fb-96f9-e18ff97bd1b0","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6248e49f-183f-5012-b8be-5fecfed55179","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"59da5ba6-9602-5e3c-9fa7-01b556316fbe","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"31dfda31-da84-5592-9695-d7dfc3dbdaee","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"0ec66249-42a4-5c0d-8a37-f2632ca7acde"}},"staticQueryHashes":["3666801979"]}